Viability-Dependent and Structural Modulation of IL-10 Secretion in THP-1 Cells by Lactobacillus gasseri and Lacticaseibacillus rhamnosus
This study demonstrates that while structural components of *Lactobacillus gasseri* and *Lacticaseibacillus rhamnosus* are sufficient to induce IL-10 secretion in THP-1 cells, live bacterial preparations elicit a significantly more robust and rapid transcriptional response, highlighting the critical role of viability in amplifying anti-inflammatory modulation.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer
The human body maintains a delicate balance between fighting infection and keeping the peace. When the immune system encounters a threat, it sends out alarm signals to mobilize defenses, but it also produces calming signals to prevent those defenses from causing collateral damage. One of the most important of these calming signals is a protein called interleukin-10, or IL-10. This molecule acts as a brake on inflammation, telling immune cells to stand down once a threat is neutralized. For decades, scientists have looked to probiotics—beneficial bacteria found in yogurt and supplements—as a way to boost this calming signal. The traditional view held that these bacteria had to be alive and active inside the body to work their magic. However, a growing body of research suggests that even dead bacteria might still carry the instructions needed to soothe the immune system, much like a letter remains readable even after the envelope is torn open. This idea has opened the door to using "paraprobiotics," which are non-living bacterial preparations that could be safer and more stable than live cultures, especially for people with weakened immune systems.
A team of researchers set out to test exactly how much the life or death of a bacterium matters when it comes to triggering this calming response. They focused on two well-known strains of beneficial bacteria: Lactobacillus gasseri and Lacticaseibacillus rhamnosus. These strains are famous for their ability to interact with the human gut and immune system. The scientists wanted to know if the bacteria needed to be alive to produce IL-10, or if their physical structure alone was enough to send the signal. To find out, they worked with a specific type of human immune cell in a laboratory dish, known as a THP-1 monocyte. These cells act as the body's first responders, ready to release cytokines like IL-10 when they detect bacteria. The researchers prepared the bacteria in several different ways: some were kept alive, some were partially weakened, and others were completely killed using heat, ultraviolet light, sound waves, or chemicals. They made sure to use the same amount of bacterial material in each test so that any differences in the results would be due to the state of the bacteria, not the quantity.
Before measuring the immune response, the team had to ensure that their bacterial preparations were safe for the human cells. They ran a series of tests to check if the bacteria were poisoning the cells or causing them to die. The results showed that none of the preparations, whether the bacteria were alive or dead, harmed the human cells. The cells remained healthy and active, which meant the scientists could confidently measure the immune signals without worrying that the bacteria were simply killing the cells off. With safety confirmed, they moved on to the core experiment: measuring how much IL-10 the cells produced. They looked at this in three different ways. First, they measured the amount of IL-10 protein floating in the liquid surrounding the cells. Second, they checked how much genetic instruction, or mRNA, the cells were making to build that protein. Third, they looked inside individual cells to see how many of them were actually making the protein.
The findings revealed a clear distinction between live and dead bacteria, though both were effective. When the cells were exposed to live bacteria, they responded quickly and strongly. The genetic instructions for IL-10 surged, reaching their highest point between 16 and 20 hours after the bacteria were introduced. This rapid and robust response suggests that the living bacteria do more than just sit there; their active metabolism seems to amplify the signal, pushing the immune cells to produce more of the calming protein. However, the dead bacteria were not useless. Even when the bacteria were completely killed and their structures were broken down, they still triggered the cells to produce IL-10. This confirms that the physical parts of the bacteria, such as their cell walls and surface proteins, contain the necessary information to tell the immune system to calm down. The dead bacteria acted as a reliable, albeit slightly weaker, trigger for the same response.
One of the most striking discoveries in the study was what happened when the researchers mixed the two different bacterial strains together. Whether the bacteria were alive or dead, combining them created a much stronger effect than using either one alone. When the live strains were mixed, the cells produced the highest levels of IL-10, far exceeding what was seen with single strains. This suggests that the two types of bacteria work together in a cooperative way, perhaps by engaging multiple different sensors on the immune cells at the same time. Even the mixture of dead bacteria showed a significant boost compared to single dead strains, proving that the synergy between different types of bacteria is a powerful factor, regardless of whether they are alive. The researchers also noted that the method used to kill the bacteria mattered. Bacteria killed with ultraviolet light retained more of their structural integrity and triggered a stronger response than those killed with heat or sound waves, which caused more damage to their physical makeup.
The study concludes that while live bacteria are the most potent triggers for this calming immune response, they are not the only ones that work. The structural components of the bacteria are sufficient to start the process, which supports the idea that non-living bacterial preparations could be used as effective treatments. This is particularly important for medical applications where live bacteria might be risky, such as in patients with severely compromised immune systems. The research provides a detailed map of how these interactions work, showing that the timing and strength of the response depend heavily on whether the bacteria are alive and whether different strains are working together. By understanding that both the life of the bacteria and its physical structure play roles, scientists can now design better treatments that balance safety with effectiveness. The work suggests that future therapies could be tailored to specific needs, using live mixed strains for maximum power or dead structural components for stability and safety, all aimed at helping the body maintain its essential peace.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.